HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...
Main Authors: | Goulbourne, C, Vaux, D |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Portland Press
2010
|
פריטים דומים
-
The structural basis of ZMPSTE24-dependent laminopathies
מאת: Quigley, A, et al.
יצא לאור: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
מאת: Quigley, A, et al.
יצא לאור: (2013) -
Prelamin A and ZMPSTE24 in premature and physiological aging
מאת: Howard J. Worman, et al.
יצא לאור: (2023-12-01) -
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
מאת: Moritz Messner, et al.
יצא לאור: (2020-08-01) -
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
מאת: Jemima Barrowman, et al.
יצא לאור: (2012-01-01)